Skip to content

News Releases

 
News Releases
  Date Title and Summary View
Oct 16, 2000
FT. WASHINGTON, Pa., Oct. 16 -- The U.S. Food and Drug Administration today approved for marketing Pepcid® Complete, a new way to treat heartburn and acid indigestion for the approximate 100 million consumers who suffer from these problems. Pepcid Complete is the first and only non- prescription, combination hear...
Sep 28, 2000
ADVISORY...for Thursday NOTE TO EDITORS: Multimedia Assets Available With This Story Include Video, Corporate Logos, Full Text Release --Sept. 28, 2000--The Women's Museum: An Institute for the Future, a unique national museum, established in association with the Smithsonian Institution, opens to the public on September 29 in D...
Sep 26, 2000
--In preparation for the first cold and flu season of the new millennium, pharmacists across the country are participating in the Medicine Cabinet Safety campaign, an educational program designed to inform consumers about the three "R's" of maintaining a well-stocked medicine cabinet. You can reach the story directly by going to ...
Sep 26, 2000
MIAMI, Sept. 26 -- Cordis Neurovascular today reported U.S. Food and Drug Administration (FDA) approval of the Company's new TRUFILL® n-BCA* Liquid Embolic System for presurgical embolization of cerebral arteriovenous malformations (AVMs: a tangle of abnormally connecting arteries and veins). Cordis Neurovascular, In...
Jul 18, 2000
NEW BRUNSWICK, N.J., July 18 -- Johnson & Johnson (NYSE: JNJ) today announced record sales of $7.5 billion and record net earnings of $1.3 billion for the second quarter of 2000, increases of 7.7% and 14.3%, respectively, over 1999 second-quarter results. Diluted earnings per share for the second quarter were $.94, up 14.6% from the same period in ...
Jun 25, 2000
JACKSONVILLE, Fla., July 25 -- According to a recent Roper Starch survey of American adults, 67 percent currently wear some form of vision correction. Yet, making sense of the latest vision care information can prove difficult for some. While the eye care survey found that eight out of 10 adults believe they understand all the eye care options avai...
Jun 22, 2000
JACKSONVILLE, Fla., June 22 -- The VISTAKON® Division of Johnson & Johnson Vision Care, Inc. announced today the availability of the ACUVUE® Brand TORIC Contact Lens, featuring a breakthrough Dual Thin Zone Stabilization Design that enhances patient satisfaction and increases ...
May 12, 2000
FORT WASHINGTON, Pa.--May 1, 2000--McNeil Consumer Healthcare today announced the national introduction of Motrin® Migraine Pain, the first over-the-counter (OTC) ibuprofen product in the rapidly growing OTC migraine category. Motrin Migraine Pain was approved by the U.S. Food and Drug Administration (FDA) on Feb...
Apr 19, 2000
NEW BRUNSWICK, N.J., April 19 -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 14.3% increase in the quarterly dividend rate, from $0.28 per share to $0.32 per share. The increase was announced this morning at the Annual Shareowners Meeting in New Brunswick, NJ. "In recognition of our strong financ...
Apr 18, 2000
NEW BRUNSWICK, N.J., April 18 -- Johnson & Johnson (NYSE: JNJ) today announced record sales of $7.3 billion and record net earnings of $1.3 billion for the first quarter of 2000, increases of 8.6% and 15.5%, respectively, over 1999 first-quarter results. Diluted earnings per share for the first quarter were $.93, up 16.3% from the same period in 19...
Page: FirstPrevious ...
167
NextLast
= add release to Briefcase